Medical information Clinical review pending

Cytogenetics

Immunohistochemistry BCL6 Test

The Immunohistochemistry BCL6 Test helps diagnose and manage certain cancers by detecting the BCL6 protein in tumor tissue. This test provides valuable information for treatment decisions.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Tumor tissue sample. Acceptable forms include tissue in 10% Formal-saline or a formalin-fixed paraffin embedded block.
Results: Results are typically available within 5 to 7 days. Confirm with the laboratory before booking.
Preparation: No specific patient preparation is required. Ensure the sample is correctly collected and submitted with relevant clinical information, including the histopathology report and site of biopsy.

Test priceKSh 7,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunohistochemistry BCL6 Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Diagnosis of lymphomas
✓Classification of certain cancers
✓Guiding treatment decisions
✓Assessing prognosis
✓Monitoring treatment response (in specific contexts)

In plain language

What this test helps you understand

Aids in the diagnosis and classification of certain lymphomas and other malignancies by assessing BCL6 protein expression in tumor tissue. Helps guide treatment decisions and prognosis.

The Immunohistochemistry BCL6 Test is a diagnostic procedure used in oncology to detect the expression of the BCL6 gene within tumor tissues. This information is critical for diagnosing certain types of cancers, particularly lymphomas, and guiding treatment strategies. Understanding the molecular characteristics of a tumor, like BCL6 expression, can significantly impact patient outcomes. This test measures the presence and levels of the BCL6 protein in a tumor sample. BCL6 is a protein involved in the development of some cancers. Analyzing its expression helps healthcare providers understand the tumor's behavior and potential response to therapies. This test is typically recommended for patients diagnosed with lymphomas or other cancers where BCL6 expression is relevant to diagnosis or treatment planning. Discuss with your oncologist if this test is appropriate for you. The results provide crucial information for accurate cancer diagnosis, help tailor treatment plans, monitor treatment effectiveness, and understand prognosis. Results indicate the presence and level of BCL6 protein in the tumor tissue. Your oncologist will interpret these results in the context of your overall health and treatment plan.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific patient preparation is required. Ensure the sample is correctly collected and submitted with relevant clinical information, including the histopathology report and site of biopsy.

SampleTumor tissue sample. Acceptable forms include tissue in 10% Formal-saline or a formalin-fixed paraffin embedded block.

MethodologyImmunohistochemistry (IHC) using antibodies specific to the BCL6 protein.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

Results must be interpreted by a qualified healthcare professional in the context of the patient's clinical history, physical examination, and other diagnostic tests. The test detects BCL6 protein expression but does not provide information on all genetic alterations.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

This test detects the presence and level of the BCL6 protein in a tumor tissue sample, aiding in the diagnosis and management of certain cancers, especially lymphomas.

It helps doctors diagnose specific types of cancer, classify them accurately, and make informed decisions about the best treatment plan for the patient.

A tumor tissue sample is required. This can be submitted as tissue in 10% Formal-saline or as a formalin-fixed paraffin embedded block.

Results are typically available within 5 to 7 days, but this can vary. Please confirm the current turnaround time with the laboratory.

A pathologist analyzes the test results. Your oncologist will discuss the findings with you and explain their significance in relation to your specific condition.

No specific patient preparation is required for this test. The sample needs to be collected and submitted correctly by your doctor.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp